Saba Capital Management Amends Stake in BlackRock Tech Trust

TL;DR

Saba Capital filed an amendment on their BlackRock Science & Technology Term Trust stake. Watch for potential changes.

AI Summary

Saba Capital Management, L.P. filed an amendment (No. 2) to its Schedule 13D on March 11, 2024, regarding its holdings in BlackRock Science & Technology Term Trust. The filing indicates a change in the beneficial ownership of the common shares of the issuer.

Why It Matters

This filing signals potential shifts in activist investor strategy or holdings within the BlackRock Science & Technology Term Trust, which could influence the trust's future performance or management.

Risk Assessment

Risk Level: medium — Amendments to Schedule 13D filings by significant holders like Saba Capital can indicate changes in investment strategy or potential activism, which may introduce volatility.

Key Players & Entities

• Saba Capital Management, L.P. (company) — Filing entity
• BlackRock Science & Technology Term Trust (company) — Subject company
• Boaz R. Weinstein (person) — Group member of Saba Capital
• Saba Capital Management GP, LLC (company) — Group member of Saba Capital

FAQ

Key Financial Figures

• $0.001 — rust (Name of Issuer) Common Shares, $0.001 par value (Title of Class of Securiti
• $95,886,948 — ported herein. A total of approximately $95,886,948 was paid to acquire the Common Shares r

Filing Documents

• formsc13da.htm (SC 13D/A) — 62KB
• 0001062993-24-006085.txt ( ) — 64KB

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of his or its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct. Date: March 11, 2024 SABA CAPITAL MANAGEMENT, L.P. By: /s/ Michael D'Angelo Name: Michael D'Angelo Title: Chief Compliance Officer SABA CAPITAL MANAGEMENT GP, LLC By: /s/ Michael D'Angelo Name: Michael D'Angelo Title: Authorized Signatory BOAZ R. WEINSTEIN By: /s/ Michael D'Angelo Name: Michael D'Angelo Title: Attorney-in-fact* * Pursuant to a power of attorney dated as of November 16, 2015, which is incorporated herein by reference to Exhibit 2 to the Schedule 13G filed by the Reporting Persons on December 28, 2015, accession number: 0001062993-15-006823 CUSIP No. 09260K101 SCHEDULE 13D/A Page 7 of 7 Pages Schedule A This Schedule sets forth information with respect to each purchase and sale of Common Shares which were effectuated by Saba Capital since the filing of the Schedule 13D/A on 2/20/24. All transactions were effectuated in the open market through a broker. Trade Date Buy/Sell Shares Price 2/20/2024 Buy 40,977 18.19 2/21/2024 Buy 3,673 18.09 2/22/2024 Buy 45,056 18.71 2/23/2024 Buy 111,494 18.76 2/26/2024 Buy 126,495 18.84 2/27/2024 Buy 115,858 18.87 2/28/2024 Buy 9,192 18.59 2/29/2024 Buy 21,755 18.69 3/1/2024 Buy 91,347 18.77 3/5/2024 Buy 34,971 18.63 3/6/2024 Buy 51,178 18.87 3/7/2024 Buy 77,737 19.28 3/8/2024 Buy 102,790 19.29

View Full Filing

View this SC 13D/A filing on SEC EDGAR